Search Within

Head and Neck Service

  1. "Shrujal Baxi"
Formats
  1. Meeting Abstract (30)
  2. Journal Article (28)
  3. Book Section (2)
  4. Research Letter (1)
Groups
  1. Department of Medicine (61)
  2. Solid Tumor Oncology Division (61)
  3. Radiation Oncology, Department of (26)
  4. Survivorship Research (26)
  5. Radiology, Department of (24)
  6. Epidemiology and Biostatistics (23)

More Groups

People
  1. Shrujal Baxi (61)
  2. David Pfister (51)
  3. Eric Sherman (43)
  4. Alan Ho (29)
  5. Nancy Lee (24)
  6. Lara Dunn (20)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2021 (1)
  4. 2020 (1)
  5. 2019 (3)
  6. 2018 (5)

More Years

Publications
  1. Journal of Clinical Oncology (26)
  2. International Journal of Radiation Oncology, Biology, Physics (8)
  3. Cancer (5)
  4. Head & Neck (4)
  5. Annals of Oncology (3)
  6. Journal of the National Comprehensive Cancer Network (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (28)
  2. Elsevier Inc. (9)
  3. Wiley Blackwell (6)
  4. John Wiley & Sons, Inc. (4)
  5. Oxford University Press (4)
  6. Harborside Press (2)

More Publishers

Results (61)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of lenvatinib plus pembrolizumab in patients with progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Mohamadpour, M.; Sherman, E. J.; Kriplani, A.; Fetten, J. V.; Dunn, L.; Michel, L. S.; Hung, K. W.; Baxi, S. S.; McDonald, E.; Conybeare, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Enhancing radioiodine incorporation in BRAF-mutant, radioiodine-refractory thyroid cancers with vemurafenib and the anti-ERBB3 monoclonal antibody CDX-3379: Results of a pilot clinical trial
    Journal Article

    Tchekmedyian, V.; Dunn, L.; Sherman, E.; Baxi, S. S.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Randomized phase II trial of nivolumab with stereotactic body radiotherapy versus nivolumab alone in metastatic head and neck squamous cell carcinoma
    Journal Article

    McBride, S.; Sherman, E.; Tsai, C. J.; Baxi, S.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D.; Michel, L. S.; Young, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase 1b study of cetuximab and BYL719 (alpelisib) concurrent with intensity modulated radiation therapy in stage III-IVB head and neck squamous cell carcinoma
    Journal Article

    Dunn, L. A.; Riaz, N.; Fury, M. G.; McBride, S. M.; Michel, L.; Lee, N. Y.; Sherman, E. J.; Baxi, S. S.; Haque, S. S.; Katabi, N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer
    Journal Article

    Sherman, E. J.; Dunn, L. A.; Schòˆder, H.; Ho, A. L.; Baxi, S. S.; Ghossein, R. A.; Haque, S. S.; Sima, C.; Tuttle, R. M.; Pfister, D. G.
    Cancer (2019)

    Fulltext@MSK | Save
  • Vemurafenib redifferentiation of BRAF mutant, RAI-refractory thyroid cancers
    Journal Article

    Dunn, L. A.; Sherman, E. J.; Baxi, S. S.; Tchekmedyian, V.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Journal of Clinical Endocrinology and Metabolism (2019)

    Fulltext@MSK | Save
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    McBride, S. M.; Sherman, E. J.; Tsai, C. J.; Baxi, S. S.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D. C.; Michel, L. S.; Spielsinger, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Long-term quality of life in older patients with HPV-related oropharyngeal cancer
    Journal Article

    Baxi, S. S.; Cullen, G.; Xiao, H.; Atoria, C. L.; Sherman, E. J.; Ho, A.; Lee, N. Y.; Elkin, E. B.; Pfister, D. G.
    Head & Neck (2018)

    Fulltext@MSK | Save